Eduardo Vilar-Sánchez
Eduardo Vilar-Sánchez is a Spanish researcher and professor of Clinical Cancer Prevention at the MD Anderson Cancer Center, University of Texas. He led a groundbreaking clinical trial demonstrating the efficacy of the NOUS-209 vaccine in stimulating immune responses in individuals with Lynch syndrome, highlighting its potential in cancer interception.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Dr. Eduardo Vilar-Sanchez expects a larger study to begin early next year based on the promising results of the vaccine tested by Norton.
8
Canada:
Eduardo Vilar-Sanchez is the trial leader of Nous-209 and discussed the potential of preventative vaccines for Lynch carriers.
8
Dominican Republic:
Eduardo Vilar-Sánchez is a Spanish researcher who led the study on the NOUS-209 vaccine.
9